Does Rallies show 13F holders for KMTS?

Yes. Rallies tracks hedge fund and 13F ownership data for KMTS, including fund names, share counts, latest tracked quarter, and position changes when available.

Is KMTS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for KMTS. It does not provide personalized investment advice.

KMTS (Kestra Medical Technologies, Ltd. Common Stock) Stock Analysis - Hedge Fund Holdings

Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a publicly traded Healthcare sector company. As of May 21, 2026, KMTS trades at $20.76 with a market cap of $1.14B and a P/E ratio of -4.05. KMTS moved +4.70% today. Year to date, KMTS is -14.99%; over the trailing twelve months it is -16.69%. Its 52-week range spans $13.25 to $30.00. Analyst consensus is strong buy with an average price target of $27.00. Rallies surfaces KMTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns KMTS stock?

Hedge funds tracked by Rallies that own KMTS include Orbimed Advisors and Soros Fund. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Kestra Medical Technologies, Ltd. Common Stock.

KMTS Key Metrics

Key financial metrics for KMTS
Metric	Value
Price	$20.76
Market Cap	$1.14B
P/E Ratio	-4.05
EPS	$-5.13
Dividend Yield	0.00%
52-Week High	$30.00
52-Week Low	$13.25
Volume	5
Avg Volume	0
Revenue (TTM)	$59.81M
Net Income	$-113.81M
Gross Margin	40.48%

Top Hedge Funds Holding KMTS

Orbimed Advisors holds 250.00K shares of KMTS, changed +0.00% as of Mar 31, 2025.
Soros Fund holds 15.00K shares of KMTS, changed +0.00% as of Jun 30, 2025.

Latest KMTS News

Kestra Medical Earns 2026 USA TODAY Top Workplaces Award Based on Employee Feedback — Apr 9, 2026
Kestra Medical Posts 63% Revenue Growth to $24.6M, GAAP Loss Widens to $34.2M — Mar 18, 2026
Kestra Medical Injects $5M into Biobeat Partnership to Add Continuous BP Monitoring to ASSURE WCD — Jan 14, 2026

Recent KMTS Insider Trades

Webster Brian Daniel sold 8.15K (~$167.41K) on May 15, 2026.
Webster Brian Daniel sold 6.84K (~$146.92K) on May 15, 2026.
Webster Brian Daniel sold 15.00K (~$300.67K) on Apr 15, 2026.

KMTS Analyst Consensus

6 analysts cover KMTS: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.00.

Common questions about KMTS

Who owns KMTS stock?: Hedge funds tracked by Rallies that own KMTS include Orbimed Advisors and Soros Fund. The latest tracked quarter is Mar 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Kestra Medical Technologies, Ltd. Common Stock.
Does Rallies show 13F holders for KMTS?: Yes. Rallies tracks hedge fund and 13F ownership data for KMTS, including fund names, share counts, latest tracked quarter, and position changes when available.
Is KMTS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for KMTS. It does not provide personalized investment advice.